References
Wylie A (1993) Apoptosis. Br J Cancer 67:205–208
Sachs L, Lotem J (1993) Control of programmed cell death in normal and leukemic cells: new implications for therapy. Blood 82:15–21
Raff M (1992) Social controls on cell survival and cell death. Nature 356:397–400
Collins M, Perkins G, Rodriguez-Tarduchy G et al. (1994) Growth factors as survival factors: regulation of apoptosis. Bioessays 16:133–138
Vaux D, Haecker G, Strasser A (1994) An evolutionary perspective on apoptosis. Cell 76:777–779
Martin S, Green D, Cotter T (1994) Dicing with death: dissecting the components of the apoptosis machinery. TIBS 19:26–30
Kerr J, Wyllie A, Currie A (1972) Apoptosis: a basci biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239–257
Kerr J, Harmon B (1991) Definition and incidence of apoptosis: an historical perspective. In: Tomei L, Cope F (eds) Apoptosis: the molecular basis of cell death. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp 5–29
Wyllie A, Kerr J, Currie A (1980) Cell death: the significance of apoptosis. Int Rev Cytol 68:251–306
Murgia M, Piio P, Sandona D et al. (1992) Mitochondrial DNA is not fragmented during apoptosis. J Biol Chem 267:10939–10941
Tepper C, Studzinski G (1993) Resistance of mitochondrial DNA to degradation characterizes the apoptotic but not the necrotic mode of human leukemia cell death. Cell Biochem 52:352–361
Nikonova L, Beletsky I, Umansky S (1993) Properties of some nuclear nucleases of rat thymocytes and their changes in radiation-induced apoptosis. Eur J Biochem 215:893–901
Ucker D, Obermiller P, Eckhart W et al. (1992) Genome digestion is a dispensable consequence of physiological cell death mediated by cytotoxic T lymphocytes. Mol Cell Biol 12:3060–3069
Peitsch M, Polzar B, Stephan H et al. (1993) Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis. EMBO J 12:371–377
Schwartzman R, Cidlowski J (1993) Mechanism of tissuespecific induction of internucleosomal DNA cleavage activity and apoptosis by glucocorticoids. Endrocrinology 133:591–599
Barry M, Eastman A (1993) Identification of deoxyribonuclease II as an endonuclease involved in apoptosis. Arch Biochem Biophys 300:440–450
Alnemri E, Litwack G (1990) Activation of internucleosomal DNA cleavage in human CEM lymphocytes by glucorticoid and novobiocin. J Biol Chem 265:17323–17333
Adamietz P (1987) Poly(ADP-ribose)synthase is the major endogenous nonhistone acceptor for poly(ADP-ribose) in alkylated rat hepatoma cells. Eur J Biochem 169:365–372
Satoh M, Lindahl T (1993) Role of poly(ADP-ribose) formation in DNA repair. Nature 356:356–358
Nelipovich P, Nikonova L, Umansky S (1988) Inhibition of poly(ADP-ribose)polymerase as a possible reason for activation of Ca/Mg-dependent endonuclease in thymocytes of irradiated rats. Int J Radiat Biol 53:749–765
Umansky S (1991) Apoptotic process in the radiation-induced death of lymphocytes. In: Tomei L, Cope F (eds) Apoptosis: the molecular basis of cell death. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp 193–207
Yoshihara K, Tanigawa Y, Burzio L et al. (1975) Evidence for ADP ribosylation of Ca/Mg-dependent endonuclease. Proc Nat Acad Sci USA 72:289–293
Rice W, Hillyier C, Harten B et al. (1992) Induction of endonuclease-mediated apoptosis in tumor cells by C-nitrososubstituted ligands of poly(ADP-ribose)polymerase. Proc Nat Acad Sci USA 89:7703–7707
Wielckens K, Delfs T (1986) Glucocorticoid-induced cell death and pol(ADP-ribosyl)ation. Endocrinology 119:2383–2392
Berger N, Berger S, Sudar D et al. (1987) Role of NAD and ATP in glucocorticoid-induced cytoxicity in susceptible lymphocytes. J Clin Invest 79:1558–1563
Chatterjee S, Trivedi D, Petzold S et al. (1990) Mechanism of epipodophyllotoxin-induced cell death in poly(ADP-ribose) synthesis-deficient V79 CHO cell lines. Cancer Res 50:2713–2718
Barbieri D, Troiano L, Grassilli et al. (1992) Inhibition of apoptosis by Zn: a reappraisal. Biochem Biophys Res Comm 187:1256–1261
Schraufstätter I, Hyslop P, Hinshaw D et al. (1986) Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose)polymerase. Proc Nat Acad Sci USA 83:4908–4912
Hayward A, Herberger M (1988) Nicotinamide protects target cells from cell-mediated cytolysis. Cell Immunol 113:414–422
Wright S, Kumar P, Tam A (1992) Apoptosis and DNA-fragmentation precede TNF-induced cytolysis in U937 cells. J Cell Biochem 48:344–355
Aggarwal S, Drysdale E, Shin H (1988) TNF-mediated cytotoxicity involves ADP-ribosylation. J Immunol 140:4187–4192
Tanizawa A, Kubota M, Hashimoto H (1989) VP16-induced nucleotide pool changes and poly(ADP-ribose) synthesis. Exp Cell Res 185:237–246
Sorenson C, Barry M, Eastman A (1990) Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. J Natl Cancer Inst 82:749–755
Grassilli E, Carcereri de Prati A et al. (1992) Studies of the relationship between proliferation and cell death II. Biochem Biophys Res Comm 188:1261–1266
Smith G, Duch D, Dev I et al. (1992) Metabolic effects and kill of human T-cell leukemia by 5-DACTHF, a specific inhibitor of glycineamide ribonucleotide transformylase. Cancer Res 52:4895–4903
Kaufmann S (1989) Induction of endonucleolytic DNA cleavage in inhuman AML cells by etoposide, camptothecin and other cytotoxic anticancer drugs. Cancer Res 49:5870–5878
Kaufmann, S, Desnoyer S, Ottaviano Y et al. (1993) Specific proteolytic cleavage of poly(ADP-ribose)polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 53:3976–3985
Tomei L, Shapiro J, Cope F (1993) Apoptosis in C3H/10T1/2 mouse embryonic cells: evidence for internucleosomal DNA modification in the absence of double-strand cleavage. Proc Nat Acad Sci USA 90:853–857
Oberhammer F, Wilson J, Dive C et al. (1993) Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in absence of internucleosomal fragmentation. EMBO J 12:3679–3684
Catchpoole D, Stewart B (1993) Etoposide-induced cytotoxicity in two human T-cell leukemic cell lines. Cancer Res 53:4287–4296
Schulze-Osthoff K (1993) Apoptosis by APO-1/Fas antigen can still be induced in enucleated cells.
Schwartz L, Smith S, Jones M et al. (1993) Do all programmed cell deaths occur via apoptosis? Proc Nat Acad Sci USA 90:980–984
Lockshin R, Zakeri Z (1991) Programmed cell death and apoptosis. In: Tomei L, Cope F (eds) Apoptosis: the molecular basis of cell death. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp 47–59
Walker P, Smith C, Youdale T et al. (1991) Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes. Cancer Res 51:1078–1085
Kung A, Zetterberg A, Sherwood S et al. (1990) Cytotoxic effects of cell cylce phase-specific agents. Cancer Res 50:7307–7317
Barry M, Behnke C, Eastman A (1990) Activation of programmed cell death by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol 40:2353–2362
Thakkar N, Potten C (1992) Abrogation of adriamycin toxicity in vivo by cycloheximide. Biochem Pharmacol 43:1683–1691
Robertson L, Chubb S, Meyn R (1993) Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-CldAdo and F-ara-A. Blood 81:143–150
Collins R, Harmon B, Souvlis T et al. (1991) Effects of cycloheximide on B-chronic lymphocytic leukemic and normal lymphocytes in vitro. Br J Cancer 64:518–522
Manchester K, Heston W, Donner D (1993) TNF-induced cytotoxicity is accompanied by intracellular mitogenic signals in ME-180 human cervical carcinoma cells. Biochem J 290:185–190
Fesus L (1993) Biochemical events in naturally occurring forms of cell death. FEBS Lett 328:1–5
Gentile V, Thomazy, Piacentini M et al. (1992) Expression of tissue transglutaminase in balb-C 3T3 fibroblasts. J Cell Biol 119:463–474
Ishida Y, Agata Y, Shibahara K et al. (1992) Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J 11:3887–3895
Owens G, Hahn W, Cohen J (1991) Identification of mRNAs associated with programmed cell death in immature thymocytes. Mol Cell Biol 11:4177–4188
Kyprianou N, Alexander R, Isaacs J (1991) Activation of programmed cell death by rhTNF plus topoisomerase II-targeted drugs in L929 tumor cells. J Natl Cancer Inst 83:346–350
Wärri A, Huovinen R, Laine A et al. (1993) Apoptosis in torimefene-induced growth inhibition of human breast cancer cells in vivo and in vitro. J Natl Cancer Inst 85:1412–1418
Kyprianou N, English H, Davidson N et al. (1991) Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res 51:162–166
Lotem J, Cragoe E, Sachs L (1991) Rescue from programmed cell death in leukemic and normal myeloid cells. Blood 78:953–960
Gong J, Li X, Darzynkiewicz Z (1993) Different patterns of apoptosis in HL-60 cells induced by cycloheximide and camptothecin. J Cell Physiol 157:263–270
Perreault J, Lemieux R (1993) Rapid apoptotic cell death of B-cell hybridomas in absence of gene expression. J Cell Physiol 156:286–293
Karnieli E, Garvey W, Olefsky J et al. (1993) Potential role for insulin and cycloheximide in regulating the intrinsic activity of glucose transporters in isolated rat adipocytes. Endocrinology 133:2943–2950
Thakkar N, Potten C (1993) Inhibition of doxorubicin-induced apoptosis in vivo by 2-deoxy-d-glucose. Cancer Res 53:2057–2060
Volland S, Amtmann E, Sauer G (1992) Glucose depletion enhances the antitumor effect of TNF. Int J Cancer 52:384–390
Albina J, Cui S, Mateo R et al. (1993) Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol 11:5080–5085
Das S, Berger N (1986) Alterations in deoxynucleoside triphosphate metabolism in DNA damaged cells. Biochem Biophys Res Comm 137:1153–1158
Davies M, Halldorson H, Shall S et al. (1976) Poly(ADP-ribose), NAD levels and some cytotoxic drugs. In: Hilz H (ed) Proc 4th Int Symposium on Poly(ADP-ribose) and Poly(ADP-ribosyl)ation of proteins, Hamburg, Walter de Gruyter, Berlin, New York
Savill J, Hogg N, Ren Y et al. (1992) Thrombospondin coop- erates with CD 36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J Clin Invest 90:1513–1522
Carson D, Seto S, Wasson B et al. (1986) DNA strand breaks, NAD metabolism and programmed cell death. Exp Cell Res 164:273–281
Malorni W, Rivabene R, Santini M et al. (1993) N-acetylcysteine inhibits apoptosis and decreases viral particles in HIV-chronically infected U937 cells. FEBS Lett 327:75–78
Schulze-Osthoff K, Bakker A, Vanhaesebroeck B et al. (1992) Cytotoxic activity of TNF is mediated by early damage of mitochondrial function. J Biol Chem 267:5317–5323
Lander M, Sehajpal P, Levine D et al. (1993) Activation of human peripheral blood mononuclear cells by NO-generating compounds. J Immunol 150:1509–1516
Laster S, Wood J, Gooding I (1988) TNF can induce both apoptotic and necrotic forms of cell lysis. J Immunol 141:2629–2634
Itoh N, Yonehara S, Ishii A et al. (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233–243
Oehm A, Behrmann I, Falk W et al. (1992) Purification and molecular cloning of the APO-1 cell surface antigen, a member of the TNF/NGF receptor superfamily. J Biol Chem 267:10709–10715
Tartaglia L, Ayres T, Wong G et al. (1993) A novel domain within the 55-kd TNF receptor signals cell death. Cell 74:845–853
Yonehara S, Ishii A, Yonehara M (1989) A cell killing mAb (Anti-Fas, to a cell surface antigen co-downregulated with the receptor of TNF. J Exp Med 169:1747–1756
Rouvier E, Luciani M, Golstein P (1993) Fas involvement in Ca2+-independent T-cell-mediated cytotoxicity. J Exp Med 177:195–200
Wong G, Goeddel D (1994) Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways. J Immunol 152:1751–1755
Golstein P, Ojcius D, Young D (1991) Cell death mechanisms and the immune system. Immunol Rev 121:29–65
McConkey D, Orrenius S (1991) Cellular signaling in thymocyte apoptosis. In: Tomei L, Cope F (eds) Apoptosis: the molecular basis of cell death. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp 227–245
Martikainen P, Kyprianou N, Tucker R et al. (1991) Programmed cell death of nonproliferating androgen-independent prostatic cancer cells. Cancer Res 51:4693–4700
Lennon S, Martin S, Cotter T (1991) Dose-dependent induction of apoptosis in human tumor cell lines by widely diverging stimuli. Cell Prolif 24:203–214
Bellomo G, Perotti M, Taddei F et al. (1992) TNFα induces apoptosis in mammary adenocarcinoma cells by an increase in intranuclear free Ca2+ concentration and DNA fragmentation. Cancer Res 52:1342–1346
Dowd D, MacDonald P, Komm B et al. (1992) Stable expression of the calbindin-D28K complementary DNA interferes with the apoptotic pathway in lymphocytes. Mol Endocrinol 6:1843–1848
Richter C (1993) Prooxidants and mitochondrial Ca2+: their relationship to apoptosis and oncogenesis. FEBS Lett 325:104–107
Hennet J, Richter C, Peterhans E (1993) TNFα induces superoxide anion generation in mitochondria of L929 cells. Biochem J 289:587–592
Barry M, Reynolds J, Eastman A (1993) Etoposide-induced apoptosis in human HL-60 cells is associated with intracellular acidification. Cancer Res 53:2349–2357
Bertrand R, Solary E, Jenkins E et al. (1993) Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors. Exp Cell Res 207:388–397
Trauth B, Klas C, Peters A et al. (1989) Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301–334
Batistatou A, Greene L (1993) Internucleosomal DNA cleavage and neuronal cell survival/death. J Cell Biol 122:523–532
Martin D, Johnson E (1991) Neuronal cell death and the role of apoptosis. In: Tomei L, Cope F (eds) Apoptosis: the molecular basis of cell death. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp 263–277
McConkey D, Aguilar-Santelises M et al. (1991) Induction of DNA fragmentation in chronic B-lymphocytic leukemia cells. J Immunol 146:1042–1076
Tritton T (1991) Cell death in cancer chemotherapy: the case of adriamycin. In: Tomei L, Cope F (eds) Apoptosis: the molecular basis of cell death. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp 121–137
Lanotte M, Riviere J, Hermouet S et al. (1991) Programmed cell death is induced rapidly and with positive cooperativity by activation of cAMP kinase I in a myeloid leukemia cell line. J Cell Physiol 146:73–80
Duprez E, Gjertsen T, Bernard O et al. (1993) Antiapoptotic effect of heterozygously expressed mutant RI subunit of cAMP kinase I in a rat leukemia cell line. J Biol Chem 268:8332–8340
McConkey D, Orrenius S, Okret S et al. (1993) cAMP potentiates glucocorticoid-induced endogenous endonuclease activation in thymocytes. FASEB J 7:580–585
Gruol D, Altschmied J (1993) Synergistic induction of apoptosis with glucocorticoids and 3′,5′-cAMP reveals agonist activity by RU 486. Mol Endocrinol 7:104–113
Berridge M, Tan A, Hilton C (1993) cAMP promotes cell survival and retards apoptosis in a factor-dependent bone marrow-derived cell line. Exp Hematol 21:269–276
Edwards S, Buckmaster A, Tolkovsky A (1991) The death program in cultured sympathetic neurones can be suppressed at the posttranslational level by nerve growth factor, cAMP and depolarization. J Neurochem 57:2140–2143
Howard K, Burke L, Mailhos C et al. (1993) Cell cycle arrest of proliferating neuronal cells by serum deprivation can result in either apoptosis or differentiation. J Neurochem 60:1783–1791
Boehme S, Lenardo S (1993) Propriocidal apoptosis of mature T lymphocytes occurs at S phase of the cell cycle. Eur J Immunol 23:1552–1560
Gorczyka W, Gong W, Ardelt B et al. (1993) The cell cyclerelated differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. Cancer Res 53:3186–3192
Song Q, Lavin M (1993) Calyculin A, a potent inhibitor of phosphatases-1 and -2A, prevent apoptosis. Biochem Biophys Res Comm 190:47–55
Evans C, Owen-Lynch P, Whetton A et al. (1993) Activation of the abelson tyrosine kinase activity is associated with suppression of apoptosis in hematopoietic cells. Cancer Res 53:1735–1738
Grignani F, Ferrucci P, Testa U et al. (1993) The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74:423–431
Hohmann H, Remy R, Aigner L (1992) Protein kinases negatively affect NF-κB activation by TNFα at two different stages in promyelocytic HL-60 cells. J Biol Chem 267:2065–2072
Aggarwal B, Graff K, Higuchi M et al. (1993) Regulation of two forms of the TNF receptors by phorbol esters and dibutyryl cAMP in human histiocytic lymphoma cell line U937. Lymphokine Cytokine Res 12:149–158
Labeznik Y, Cole S, Cooke C et al. (1993) Nuclear events of apoptosis in vitro in cell-free mitotic extracts. J Cell Biol 123:7–22
Nicotera P, Hartzell P, Davis G et al. (1986) The formation of membrane blebs in hepatocytes exposed to agents that increase cytosolic Ca is mediated by the activation of a non-lysosomal proteolytic system. FEBS Lett 209:139–144
Sarin A, Adams D, Henkart P (1993) Protease inhibitors selectively block T-cell receptor-triggered programmed cell death in a murine T-cell hybridoma. J Exp Med 178:1693–1700
Kumar S, Baglioni C (1991) Protection from TNF-mediated cytolysis by overexpression of PAI-2. J Biol Chem 266:20960–20964
Ciechanover A, Schwartz A (1994) The ubiquitin-mediated proteolytic pathway: mechanisms of recognition of the proteolytic substrate and involvement in the degradation of native cellular proteins. FASEB J 8:182–191
Nagaraja S, Delcuve G, Hendzel M et al. (1993) Effects of histone acetylation ubiquitination and variants on nucleosome stability. Biochem J 296:737–744
Delic J, Morange M, Magdalenat H (1993) Ubiquitin pathway involvement in human lymphocyteγ-irradiation-induced apoptosis. Mol Cell Biol 13:4875–4883
Williams G, Smith C (1993) Molecular regulation of apoptosis. Cell 74:777–779
Vaux D (1993) Towards an understanding of the molecular mechanisms of physiological cell death. Proc Nat Acad Sci USA 90:786–789
Ellis R, Jacobson M, Horvitz H (1991) Genes required for the engulfment of cell corpses during programmed cell death inC. elegans. Genetics 129:79–94
Hengartner M, Ellis R, Horvitz H (1992)C. elegans gene ced-9 protects cells from programmed cell death. Nature 356:494–499
Hengartner M, Horvitz H (1994)C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell 76:665–676
Miura M, Zhu H, Rotello R et al. (1993) Induction of apoptosis in fibroblasts by interleukin-1β-converting enzyme, a mammalian homolog of theC. elegans cell death gene ced-3. Cell 75:653–660
Korsmeyer S (1992) Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 80:879–886
Hanada M, Aiello A, Stadtmauer E et al. (1993) Bcl-2 gene hypomethylation and high-level expression in B-CLL. Blood 82:1820–1828
McDonell T, Deane N, Platt F et al. (1989) Bcl-2-immunoglobulin transgenic mice demonstrate extended B-cell survival and follicular lymphoproliferation. Cell 57:79–88
Vaux D, Weissman I, Kim S (1992) Prevention of programmed cell death inC. elegans by human bcl-2. Science 258:1955–1957
Walton M, Whysong D, O'Connor P (1993) Constitutive expression of human bcl-2 modulates nitrogen mustard and camptothecin-induced apoptosis. Cancer Res 53:1853–1861
Fisher T, Miller A, Gregory C et al. (1993) Bcl-2 modulation of apoptosis induced by anticancer drugs. Cancer Res:3321–3326
Zhong L, Sarafian T, Kane D et al. (1993) Bcl-2 inhibits death of central neural cells induced by multiple agents. Proc Nat Acad Sci USA 90:4533–4537
Mah S, Zjong T, Liu Y et al. (1993) The protooncogene bcl-2 inhibits apoptosis in PC 12 cells. J Neurochem 60:1183–1186
Fairbairn L, Cowling G, Reipert B et al. (1993) Suppression of apoptosis allows differentiation and development of a multipotent hematopoietic cell line in the absence of growth factors. Cell 74:823–832
Nunez G, London L, Hockenberry D et al. (1990) Deregulated bcl-2 gene expression selectively prolongs survival of growth factor-deprived hematopoietic cell lines. J Immunol 144:3602–3610
Otani H, Erdos M, Leonard W (1993) Tyrosine kinases regulate apoptosis and bcl-2 expression in a growth-factor-dependent cell line. J Biol Chem 268:22733–22736
Dancescu M, Rubio-Trujillo M et al. (1992) IL-4 protects CLL B cells from death by apoptosis and upregulates bcl-2 expression. J Exp Med 176:1319–1326
Vaux D, Aguila H, Weissman L (1992) Bcl-2 prevents death of factor-deprived cells but fails to prevent apoptosis in targets of cell-mediated killing. Int Immunol 4:821–824
Jacobson M, Burne J, King M et al. (1993) Bcl-2 blocks apoptosis in cell lacking mitochondrial DNA. Nature 361:365–368
Kozopas K, Yang T, Buchan H et al. (1993) MCL-1, a gene expressed in programmed myeloid cell differentiation, has sequence similaritiy to bcl-2. Proc Nat Acad Sci USA 90:3516–3520
Oltvai Z, Milliman C, Korsmeyer S (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609–619
Boise L, Gonzalez-Garcia M, Postema M et al. (1993) Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597–608
Vanhaesebroeck B, Ree J, De Valck D et al. (1993) Effect of bcl-2 protooncogene expression on cellular sensitivity to TNF-mediated cytotoxicity. Oncogene 8:1075–1081
Itoh N, Tsujimoto Y, Nagata S (1993) Effect of bcl-2 on Fas antigen-mediated cell death. J Immunol 151:621–627
Dhein J, Daniel P, Trauth B et al. (1992) Induction of apoptosis by mAb anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. J Immunol 149:3166–3173
Watanabe-Fukunaga R, Brannan C et al. (1992) Lymphoproliferation discorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314–417
Miyawaki T, Uehara T, Nibu R et al. (1992) Differential expression of apoptosis-related Fas antigen in lymphocyte subpopulations in human peripheral blood. J Immunol 149:3753–3758
Mapara M, Bargou R, Zugk C et al. (1993) APO-1-mediated apoptosis or proliferation in human B-CLL: correlation with bcl-2 oncogene expression. Eur J Immunol 23:702–708
Suda T, Takahashi T, Golstein P et al. (1993) Molecular cloning and expression of the Fas ligand, a novel member of the TNF family. Cell 75:1169–1178
Shichiri M, Hanson K, Sedivy J (1993) Effects of c-myc expression on proliferation, quiescence, and the G0 to G1 transition in nontransformed cells. Cell Growth Diff 4:93–104
Evan G, Wyllie A, Gilbert C et al. (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119–128
Arends M, McGregor A, Toft N et al. (1993) Susceptivility to apoptosis is differentially regulated by c-myc and mutated Ha-ras oncogenes and is associated with endonuclease availability. Br J Cancer 68:1127–1133
Shi Y, Glynn J, Gilbert L et al. (1992) Role of c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science 257:212–214
Wagner A, Small M, Hay N (1993) Myc-mediated apoptosis is blocked by ectopic expression of bcl-2. Mol Cell Biol 13:2432–2440
Bissonnette R, Echeverri F, Mahboubi A et al. (1992) Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359:552–554
Fanidi A, Harrington E, Evan G (1992) Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 359:554–556
Yano T, Jaffe E, Longo D et al. (1992) Myc rearrangements in histologically progressed follicular lymphomas. Blood 80:758–767
Clarke A, Purdie C, Harrison D et al. (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362:849–852
Shaw P, Bovey R, Tardy S et al. (1992) Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Nat Acad Sci USA 89:4495–4499
Yonish-Rouach E, Resnitzky D, Lotem J et al. (1991) Wildtype p53 induces apoptosis of myeloid leukemic cells that is inhibited by IL-6. Nature 352:345–347
Scheffner M, Huibregtse J, Vierstra R et al. (1993) The HPV-16 E6 and E6-AP complex functions as a ubiquitinprotein ligase in the ubiquitination of p53. Cell 75:495–505
Kastan M, Zhan Q, El-Deiry W et al. (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-teleangiectasia. Cell 71:587–597
El-Deiry W, Harper J, O'Connor P et al. (1994) WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54:1169–1174
Price B, Park S (1994) DNA damage increases the levels of mdm2 mRNA in wtp53 human cells. Cancer Res 54:896–899
Zhang X, Colombel M, Raffo A et al. (1994) Enhanced expression of p53 mRNA and protein in the regressing rat ventral prostate gland. Biochem Biophys Res Commun 198:1189–1194
Nelson W, Kastan M (1994) DNA strands breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol Cell Biol 14:1815–1823
Wang Y, Szekely L, Okan I et al. (1993) Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line. Oncogene 8:3427–3431
Gazitt Y, Erdos G (1994) Fluctuations and ultrastructural localization of oncoproteins and cell cycle regulatory proteins during growth and apoptosis of synchronized AGF cells. Cancer Res 54:950–956
Mymryk J, Shire K, Bayley S (1994) Induction of apoptosis by adenovirus type 5 E1A in rat cells requires a proliferation block. Oncogene 9:1187–1193
Williams G, Smith C, Spooncer E et al. (1990) Haematopoietic colony-stimulating factors promote cell survival by suppressing apoptosis. Nature 343:76–79
Lotem J, Sachs L (1992) Hematopoietic cytokines inhibit apoptosis by TGFβ1 and cancer chemotherapy compounds in myeloic leukemic cells. Blood 80:1750–1757
Rodriguez-Tarduchy G, Collins M, Lopez-Rivas A (1990) Regulation of apoptosis in IL-3-dependent hemopoietic cells by IL-3 and Ca ionophores. EMBO J 9:2997–3002
Duke R, Cohen J (1986) IL-2 addiction: withdrawal of growth factor activates a suicide program in dependent T cells. Lymphokine Res 5:289–299
Barres B, Hart I, Coles H et al. (1992) Cell death in the oligodendrocyte lineage. J Neurobiol 23:1221–1230
Araki S, Shimada Y, Kaji K et al. (1990) Apoptosis of vascular endothelial cells by fibroblast growth factor deprivation. Biochem Biophys Res Commun 168:1194–1200
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Binder, C., Hiddemann, W. Programmed cell death — many questions still to be answered. Ann Hematol 69, 45–55 (1994). https://doi.org/10.1007/BF01698481
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01698481